Clinical Trials on ER-positive Breast Cancer in Netherlands
Total 320 results
-
Erasmus Medical CenterRecruitingER+ Breast CancerNetherlands
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Amsterdam UMC, location VUmcAstraZenecaRecruitingBreast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric CancerNetherlands
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
Leiden University Medical CenterThe Netherlands Cancer Institute; Borstkanker Onderzoek Groep; Comprehensive... and other collaboratorsSuspendedHER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete Response | Objective Response RateNetherlands
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
University Medical Center GroningenActive, not recruiting
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Academisch Ziekenhuis MaastrichtEli Lilly and Company; Novartis; Pfizer; Gilead Sciences; Roche Pharma AG; AstraZeneca and other collaboratorsRecruitingAdvanced Breast Cancer | Metastatic Breast CancerNetherlands
-
University Medical Center GroningenCompletedMetastatic Breast CancerNetherlands
-
Radboud University Medical CenterCompleted
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingMetastatic Breast CancerNetherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerNetherlands
-
University Medical Center GroningenTerminatedLobular Metastatic Breast CancerNetherlands
-
Amsterdam UMC, location VUmcNovartis; Borstkanker Onderzoek GroepUnknownMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastNetherlands
-
University Medical Center GroningenMartini Hospital GroningenRecruitingBreast Cancer | Breast Cancer InvasiveNetherlands
-
University Medical Center GroningenCompleted
-
Radboud University Medical CenterUMC Utrecht; Erasmus Medical Center; University of Sydney; Lunit Inc.; Dutch Breast... and other collaboratorsEnrolling by invitationBreast Cancer ScreeningNetherlands
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast Cancer or Gastric CancerTaiwan, Netherlands, Italy, United States, Belgium, United Kingdom, Korea, Republic of, France, Spain
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
The Netherlands Cancer InstituteDutch Cancer SocietyCompletedBreast Cancer Survivors | Climacteric SymptomsNetherlands
-
Zuyderland Medisch CentrumHologic, Inc.RecruitingBreast Cancer | Breast Neoplasms | Breast Cancer FemaleNetherlands
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
The Netherlands Cancer InstituteDutch Cancer Society; Pink Ribbon Inc.CompletedSexual Dysfunction | Breast Cancer Survivors | Intimacy ProblemsNetherlands
-
University Medical Center GroningenCompleted
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Nij Smellinghe HosptialCompletedLymphedema | Breast Cancer Stage II | Early Disease OnsetNetherlands
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
University Medical Center GroningenAmsterdam UMC, location VUmc; University Medical Center NijmegenActive, not recruitingMetastatic Breast CancerNetherlands
-
UMC UtrechtCenter for Translational Molecular Medicine; Dutch Cancer Society; Vrienden UMC...RecruitingBreast Cancer | Breast Neoplasms | Metastatic Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Invasive Ductal Breast Cancer | Invasive Ductal Carcinoma of Female Breast | Adenocarcinoma BreastNetherlands
-
University Medical Center GroningenTechnical University of Munich; The Netherlands Cancer Institute; Institut de...CompletedBreast Cancer Female | Cardiac Complications | Acute Coronary EventsNetherlands
-
The Netherlands Cancer InstituteTerminated
-
UMC UtrechtKarolinska Institutet; German Cancer Research Center; University Hospital Heidelberg and other collaboratorsActive, not recruitingMetastatic Breast CancerNetherlands
-
University Medical Center GroningenCompleted
-
UMC UtrechtInstitut National de la Santé Et de la Recherche Médicale, France; Philips... and other collaboratorsCompleted
-
Borstkanker Onderzoek GroepSanofi; Novartis; Amgen; Dutch Cancer SocietyCompleted
-
University Medical Center GroningenMartini Hospital GroningenCompleted
-
University Medical Center GroningenCompleted
-
UMC UtrechtNational Institute for Public Health and the Environment (RIVM); Dutch Cancer...CompletedBreast CancerNetherlands
-
Zuyderland Medisch CentrumCompletedBreast CancerNetherlands
-
Maastricht Radiation OncologyCompletedBreast CancerNetherlands
-
Erasmus Medical CenterUniversity Medical Center Groningen; Leiden University Medical CenterRecruitingAdvanced Breast CancerNetherlands
-
The Netherlands Cancer InstituteRecruitingBreast Cancer Patients Undergoing Mastectomy With Immediate ReconstructionNetherlands
-
Stemline Therapeutics, Inc.CompletedMetastatic Breast CancerNetherlands, Belgium
-
The Netherlands Cancer InstituteMaarten van de Weijden FoundationRecruitingOligoprogressive | Metastatic Cancer | Breast Cancer InvasiveNetherlands